{"id":"NCT01878825","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older","officialTitle":"Immunogenicity and Safety Study of GSK Biologicals' Trivalent Split Virion Influenza Vaccine (GSK1536489A) Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07-18","primaryCompletion":"2013-08-09","completion":"2013-08-09","firstPosted":"2013-06-17","resultsPosted":"2015-01-16","lastUpdate":"2018-09-07"},"enrollment":121,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Fluviral™","otherNames":[]}],"arms":[{"label":"Fluviral 18-60 Years Group","type":"EXPERIMENTAL"},{"label":"Fluviral >60 Years Group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the immunogenicity, reactogenicity and safety of Fluviral™ containing the influenza strains recommended for the 2013-2014 season in adults aged 18 years and older.","primaryOutcome":{"measure":"Humoral Immune Response in Terms of Haemagglutination Inhibition (HI) Antibody Titers Against Each of the Three Vaccine Influenza Strains","timeFrame":"At Days 0 and 21","effectByArm":[{"arm":"Fluviral 18-60 Years Group","deltaMin":61,"sd":null},{"arm":"Fluviral >60 Years Group","deltaMin":65.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":19},"locations":{"siteCount":1,"countries":["Canada"]},"refs":{"pmids":[],"seeAlso":["https://clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":60},"commonTop":["Pain","Myalgia","Fatigue","Headache","Arthralgia"]}}